Anticancerdrugs

CRIZALK 250MG DESCRIPTION Crizalk 250mg capsule belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are contain in many functions, including cell development and reproduction. Crizalk 250mg prohibit the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This activity depresses certain pathways in the cell, which can prevent the growth of tumor cells. PRODUCT DETAILS Trade name                             Crizalk  Active component                  Crizotinib  Strength                                  250mg  Manufactured by                    Pfizer Ltd  Form                                      Capsules  Packing                                  60 tablets MECHANISM OF ACTION More specifically, crizotinibprevents anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Malformationin the ALK gene result by mutations or a

CRIZALK 200MG DESCRIPTION Crizalk 200mg capsule belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are contain in many functions, including cell development and reproduction. Crizalk 200mg prohibit the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This activitydepresses certain pathways in the cell, which can prevent the growth of tumor cells. PRODUCT DETAILS Trade name                  Crizalk  Active component        Crizotinib   Strength                       200mg  Manufactured by         Pfizer Ltd  Form                            Capsules  Packing                        60 tablets MECHANISM OF ACTION More specifically, crizotinibprevents anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Malformationin the ALK gene result by mutations or alteration may causes expression of oncogenic fusion proteins. C